// App-Quantinova.ai

: The Effect of Angiotensin II (ANG II) Infusion on Plasma Uric Acid (PUA) in Patients with Type 1 Diabetes (T1D)

Researchers

Presenter

  • YULIYA LYTVYN

Principal Investigators

  • JULIE A. LOVSHIN

  • PETTER BJORNSTAD

  • LEIF ERIK LOVBLOM

  • ALEXANDRA KATZ

  • ANDRIY LYTVYN

  • GENEVIEVE BOULET

  • MOHAMMED A. FAROOQI

  • ALANNA WEISMAN

  • HILLARY A. KEENAN

  • MICHAEL H. BRENT

  • NARINDER PAUL

  • VERA BRIL

  • ANDREW ADVANI

  • BRUCE A. PERKINS

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Type 1 diabetes mellitus

  • Renal disease

  • Hyperglycemia

  • Hypertension

  • Diabetes

Biomarkers

  • Angiogenin

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved